GROW Pharma flower Gary Payton – 22% THC + <1% CBD - 10g®

Report Abuse

grow logo grow logo
Most Viewed
0 0 Reviews
£75.00

 

GROW Pharma flower Gary Payton - 22% THC + <1% CBD® is a hybrid strain of cannabis characterised by 22%  THC and <1% CBD (content by weight).

GROW Pharma flower Gary Payton is Grown by PHCann in North Macedonia and imported into the UK by Grow Group PLC and distributed by IPS Pharma.

0%
THC
0%
CBD

Cultivar Manufacturing Terpenes
Strain: Gary Payton Origin:
North Macedonia
= Dominant

= Others

Lineage: Gary Payton Manufacturer: PHCann / Grow Pharma Description of Taste: 
Genetics: 50/50 Hybrid Grow Type: Indoor Description of Smell: 

Commonly Prescribed For 

Patient Feedback:

Effect:

Specification

Type
Hybrid
Cultivar
Gary Payton
THC
22%
CBD
<1%
Terpene 1
Caryophyllene
Terpene 2
Linalool
Terpene 3
Limonene
Terpene 4
Origin
North Macedonia
Brand
GROW Pharma | PH CANN
Post Harvesting - Bioburden Reduction Method
Non-irradiated
 

Supporting Documents

Patient Information Leaflet

Price

Sizes / Weights
10g
Current Availability
Coming Soon
Cost
10g from £75

Access Schemes

Available On Project Twenty21
Unknown

Cultivation & Manufacturing Overview

Grow Type
Indoor
Growing Method
Living Soil
Lighting Type
TBC
Post Harvesting - Drying
Dry Hung
Post Harvesting - Trimming
TBC

Gallery & Videos

Gallery

GROW Pharma flower Gary Payton – 22% THC + <1% CBD - 10g® 0 reviews

Write Your Review

There are no reviews yet.

Write Your Review

Your email address will not be published. Required fields are marked *